Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$344,343,192
+$13,949,045 QoQ
Shares Held
1,355,842
+0.3% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
1.85%
of 13F equity value
Holder Rank
#133
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 86%
Shared 10%
None 3%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KEYBANK NATIONAL ASSOCIATION/OH holds $1,077,519,603 across 14 Drug Manufacturers - General names. JNJ ranks #1 (32.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
1,355,842 | $344,343,192 | |
| 2 | ABBV |
AbbVie Inc.
|
1,184,894 | $298,166,725 | |
| 3 | LLY |
ELI LILLY & Co
|
109,086 | $130,841,031 | |
| 4 | MRK |
Merck & Co., Inc.
|
847,233 | $108,869,440 | |
| 5 | AMGN |
Amgen Inc
|
241,243 | $87,358,914 | |
| 6 | PFE |
Pfizer Inc
|
1,445,780 | $34,814,381 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
500,631 | $28,846,358 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
127,699 | $16,133,491 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $344,343,192 | 1,355,842 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $330,394,147 | 1,351,637 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $280,333,435 | 1,354,595 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $217,203,583 | 1,171,414 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $169,723,580 | 1,111,120 | Shares | Defined | 2025-08-04 | |
| 2025-03-31 | $189,158,762 | 1,140,610 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $169,868,915 | 1,174,588 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $203,939,382 | 1,258,419 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $204,055,145 | 1,396,108 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $224,379,226 | 1,418,416 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $227,590,241 | 1,452,024 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $228,363,608 | 1,466,219 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $275,277,304 | 1,663,106 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $257,174,605 | 1,659,191 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $294,425,911 | 1,666,719 | Shares | Defined | 2023-01-31 | |
| 2022-09-30 | $268,028,998 | 1,640,726 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $289,083,377 | 1,628,547 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $251,237,880 | 1,417,581 | Shares | Defined | 2022-04-28 | |
| 2021-12-31 | $242,931,373 | 1,420,070 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $230,002,163 | 1,424,162 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $236,944,552 | 1,438,294 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $239,779,746 | 1,458,958 | Shares | Defined | 2021-09-03 | |
| 2020-12-31 | $232,426,180 | 1,476,847 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $221,764,203 | 1,489,550 | Shares | Defined | 2020-10-29 | |
| 2020-06-30 | $210,618,316 | 1,497,677 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $197,863,629 | 1,508,912 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||